These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 7682587)

  • 1. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
    Mineo JR; McLeod R; Mack D; Smith J; Khan IA; Ely KH; Kasper LH
    J Immunol; 1993 May; 150(9):3951-64. PubMed ID: 7682587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30).
    Mineo JR; Kasper LH
    Exp Parasitol; 1994 Aug; 79(1):11-20. PubMed ID: 8050521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A4D12 monoclonal antibody recognizes a new linear epitope from SAG2A Toxoplasma gondii tachyzoites, identified by phage display bioselection.
    Cunha-Júnior JP; Silva DA; Silva NM; Souza MA; Souza GR; Prudencio CR; Pirovani CP; Cezar M Cascardo J; Barbosa BF; Goulart LR; Mineo JR
    Immunobiology; 2010; 215(1):26-37. PubMed ID: 19261354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages.
    Kasper LH; Khan IA; Ely KH; Buelow R; Boothroyd JC
    J Immunol; 1992 Mar; 148(5):1493-8. PubMed ID: 1538132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen.
    Darcy F; Maes P; Gras-Masse H; Auriault C; Bossus M; Deslee D; Godard I; Cesbron MF; Tartar A; Capron A
    J Immunol; 1992 Dec; 149(11):3636-41. PubMed ID: 1431132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) of Toxoplasma gondii.
    Kasper LH; Currie KM; Bradley MS
    J Immunol; 1985 May; 134(5):3426-31. PubMed ID: 3884710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response.
    Graille M; Stura EA; Bossus M; Muller BH; Letourneur O; Battail-Poirot N; Sibaï G; Gauthier M; Rolland D; Le Du MH; Ducancel F
    J Mol Biol; 2005 Nov; 354(2):447-58. PubMed ID: 16242717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii.
    Zorgi NE; Costa A; Galisteo AJ; do Nascimento N; de Andrade HF
    Immunol Lett; 2011 Aug; 138(2):187-96. PubMed ID: 21545808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of stage-specific sporozoite antigens of Toxoplasma gondii by monoclonal antibodies.
    Kasper LH; Bradley MS; Pfefferkorn ER
    J Immunol; 1984 Jan; 132(1):443-9. PubMed ID: 6197455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes.
    Rodriguez C; Afchain D; Capron A; Dissous C; Santoro F
    Eur J Immunol; 1985 Jul; 15(7):747-9. PubMed ID: 2408905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies in cold stressed mice recognize a surface protein in Toxoplasma gondii tachyzoites.
    Thompson EG; Aviles HO; Monroy FP
    J Parasitol; 2008 Feb; 94(1):114-8. PubMed ID: 18372629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii.
    Khan IA; Smith KA; Kasper LH
    J Immunol; 1988 Nov; 141(10):3600-5. PubMed ID: 2460541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice.
    Khan IA; Ely KH; Kasper LH
    J Immunol; 1991 Nov; 147(10):3501-6. PubMed ID: 1940350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
    Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
    Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model.
    Siachoque H; Guzman F; Burgos J; Patarroyo ME; Gomez Marin JE
    Exp Parasitol; 2006 Sep; 114(1):62-5. PubMed ID: 16545806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxoplasma gondii: the characterization of an anti-P30 monoclonal antibody].
    Fachado A; Fernández N; Hernández E; Fonseca L
    Rev Cubana Med Trop; 1996; 48(3):178-83. PubMed ID: 9805047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic similarity between Hammondia hammondi and Toxoplasma gondii tachyzoites.
    Riahi H; Bouteille B; Darde ML
    J Parasitol; 1998 Jun; 84(3):651-3. PubMed ID: 9645881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA antibodies to Toxoplasma gondii in human tears.
    Meek B; Klaren VN; van Haeringen NJ; Kijlstra A; Peek R
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2584-90. PubMed ID: 10937570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine immune responses to recombinant Toxoplasma gondii antigens.
    Parker SJ; Smith FM; Johnson AM
    J Parasitol; 1991 Jun; 77(3):402-9. PubMed ID: 2040952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.